SE434952B - Forfarande for framstellning av nya cefalosporinderivat - Google Patents

Forfarande for framstellning av nya cefalosporinderivat

Info

Publication number
SE434952B
SE434952B SE7610989A SE7610989A SE434952B SE 434952 B SE434952 B SE 434952B SE 7610989 A SE7610989 A SE 7610989A SE 7610989 A SE7610989 A SE 7610989A SE 434952 B SE434952 B SE 434952B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
cephalosporin derivatives
new cephalosporin
new
Prior art date
Application number
SE7610989A
Other languages
English (en)
Other versions
SE7610989L (sv
Inventor
M Kaplan
W J Gottstein
A P Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/653,999 external-priority patent/US4026888A/en
Priority claimed from US05/654,314 external-priority patent/US4061862A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7610989L publication Critical patent/SE7610989L/sv
Publication of SE434952B publication Critical patent/SE434952B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/58Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with a nitrogen atom, which is a member of a hetero ring, attached in position 7

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7610989A 1975-10-06 1976-10-04 Forfarande for framstellning av nya cefalosporinderivat SE434952B (sv)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62000575A 1975-10-06 1975-10-06
US62230675A 1975-10-10 1975-10-10
US64031775A 1975-12-12 1975-12-12
US05/653,999 US4026888A (en) 1975-10-10 1976-01-30 Certain derivatives of particular 3-thiolated cephalosporins
US05/654,314 US4061862A (en) 1975-10-06 1976-02-02 Derivatives of 7-(cyclized)phenylglycyl-3-triazolo-thio methyl cephalosporin

Publications (2)

Publication Number Publication Date
SE7610989L SE7610989L (sv) 1977-04-07
SE434952B true SE434952B (sv) 1984-08-27

Family

ID=27542000

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7610989A SE434952B (sv) 1975-10-06 1976-10-04 Forfarande for framstellning av nya cefalosporinderivat

Country Status (17)

Country Link
JP (1) JPS6052718B2 (sv)
AU (1) AU511344B2 (sv)
BE (1) BE846890A (sv)
CA (1) CA1113927A (sv)
CH (1) CH629500A5 (sv)
CY (1) CY1121A (sv)
DE (1) DE2645144C2 (sv)
DK (2) DK158673C (sv)
FR (1) FR2326926A1 (sv)
GB (1) GB1521419A (sv)
HK (1) HK41281A (sv)
IE (1) IE43666B1 (sv)
KE (1) KE3154A (sv)
LU (1) LU75935A1 (sv)
NL (1) NL189670C (sv)
SE (1) SE434952B (sv)
YU (1) YU40287B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54112892A (en) * 1978-02-23 1979-09-04 Shionogi & Co Ltd Substituted imidazolidinyl-3-chloro-3-cephem-4-carboxylic acid
JPS54115354A (en) * 1978-02-27 1979-09-07 Chugai Pharmaceut Co Ltd Biphenylylglycine derivative
JP7013048B2 (ja) * 2018-03-02 2022-01-31 国立大学法人大阪大学 タンパク質及び/又はペプチド修飾用分子

Also Published As

Publication number Publication date
DK164225B (da) 1992-05-25
DE2645144A1 (de) 1977-04-14
DE2645144C2 (de) 1986-11-27
AU1824576A (en) 1978-04-06
FR2326926A1 (fr) 1977-05-06
KE3154A (en) 1981-09-18
HK41281A (en) 1981-08-28
NL189670B (nl) 1993-01-18
SE7610989L (sv) 1977-04-07
CA1113927A (en) 1981-12-08
CH629500A5 (en) 1982-04-30
AU511344B2 (en) 1980-08-14
GB1521419A (en) 1978-08-16
YU40287B (en) 1985-12-31
DK200488A (da) 1988-04-12
IE43666B1 (en) 1981-04-22
DK200488D0 (da) 1988-04-12
FR2326926B1 (sv) 1980-07-11
NL7611026A (nl) 1977-04-12
IE43666L (en) 1977-04-06
NL189670C (nl) 1993-06-16
DK164225C (da) 1992-10-19
DK158673C (da) 1991-01-14
CY1121A (en) 1981-12-04
DK446576A (da) 1977-04-07
BE846890A (fr) 1977-04-01
DK158673B (da) 1990-07-02
YU243176A (en) 1982-06-30
JPS6052718B2 (ja) 1985-11-20
LU75935A1 (sv) 1977-05-25
JPS5246094A (en) 1977-04-12

Similar Documents

Publication Publication Date Title
SE464580B (sv) Foerfarande foer framstaellning av nya cefalosporinderivat
SE464581B (sv) Foerfarande foer famstaellning av nya cefalosporinderivat
SE7808204L (sv) Forfarande for framstellning av nya cefalosporiner
SE7513571L (sv) Forfarande for framstellning av nya substituerade pyridiner
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
SE431548B (sv) Forfarande for framstellning av nya cefalosporinderivat
SE431545B (sv) Forfarande for framstellning av nya 2-substituerade oxazolopyridiner
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE421212B (sv) Forfarande for framstellning av nya derivat av daunorubicin
SE441359B (sv) Forfarande for framstellning av nya klavulansyratioetrar
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
SE440080B (sv) Forfarande for framstellning av klavulansyraderivat
SE404801B (sv) Forfaranden for framstellning av nya tiazolderivat
SE434402B (sv) Forfarande for framstellning av nya cefalosporinderivat
SE439159B (sv) Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat
SE428688B (sv) Forfarande for framstellning av nya antidiabetiskt aktiva isooxazolderivat
SE7507481L (sv) Forfarande for framstellning av nya cefalosporinderivat.
SE435715B (sv) Forfarande for framstellning av nya penicilliner
SE7705183L (sv) Framstellning av nya bensodiazepinderivat
SE402106B (sv) Forfarande for framstellning av nya n-(Ÿ-amino)-alkylanilinderivat
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat
SE7510833L (sv) Forfarande for framstellning av nya cefalosporinderivat
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE409455B (sv) Analogiforfarande for framstellning av nitroimidazolyl-kinazolinderivat
SE7612565L (sv) Forfarande for framstellning av nya rifamycinforeningar

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7610989-1

Effective date: 19940510

Format of ref document f/p: F